Area of research
Molecular Biology · Oncology
Research interest
Research interests include Angiogenesis and VEGF in Cancer, Cancer Cells and Metastasis, Lymphatic System and Diseases, and Axon Guidance and Neuronal Signaling.
A 3D biomimetic model of lymphatics reveals cell–cell junction tightening and lymphedema via a cytokine-induced ROCK2/JAM-A complex
Promoting Lymphangiogenesis and Lymphatic Growth and Remodeling to Treat Cardiovascular and Metabolic Diseases
PRSS2 remodels the tumor microenvironment via repression of Tsp1 to stimulate tumor growth and progression
Triangular correlation (TrC) between cancer aggressiveness, cell uptake capability, and cell deformability
Epsins 1 and 2 promote NEMO linear ubiquitination via LUBAC to drive breast cancer development
Aspirin-triggered proresolving mediators stimulate resolution in cancer
Preoperative stimulation of resolution and inflammation blockade eradicates micrometastases
Suppression of chemotherapy-induced cytokine/lipid mediator surge and ovarian cancer by a dual COX-2/sEH inhibitor
Resolvins suppress tumor growth and enhance cancer therapy
Development of a prosaposin-derived therapeutic cyclic peptide that targets ovarian cancer via the tumor microenvironment
The role of EMT and MET in cancer dissemination
Bone Marrow–Derived Gr1+ Cells Can Generate a Metastasis-Resistant Microenvironment Via Induced Secretion of Thrombospondin-1
α<sub>V</sub>β<sub>3</sub> Integrin-Targeted PLGA-PEG Nanoparticles for Enhanced Anti-tumor Efficacy of a Pt(IV) Prodrug
DIAPH3 governs the cellular transition to the amoeboid tumour phenotype